Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response

Mizrahi, AG; Hamad, H; Gugenheim, A; Nisman, B; Kuznetz, A; Ben David, I; Gelfend, Y; Cohen, S; Zick, A; Sheva, K; Nechushtan, H; Peretz, T; Meirovitz, A

Meirovitz, A (通讯作者),Soroka Univ, Legacy Heritage Oncol Ctr, Med Ctr, POB 151, IL-8410101 Beer Sheva, Israel.;Meirovitz, A (通讯作者),Soroka Univ, Dr Larry Norton Inst, Med Ctr, POB 151, IL-8410101 Beer Sheva, Israel.

ANTICANCER RESEARCH, 2022; 42 (11): 5257

Abstract

Background/Aim: Tumor cell lines are essential tools in understanding the molecular mechanisms underlying cancer biology and therapeutic responses. Po......

Full Text Link